Volume 19, Number 9—September 2013
Dispatch
Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
Table 2
P1 gene type | No. isolates | Variant | Reference | GenBank accession no.† | Nucleotide homology, % | Amino acid homology, % | Nonsynonymous mutations compared with reference (no. isolates) | No. VTR AGT sequences | No. drug-resistant isolates |
---|---|---|---|---|---|---|---|---|---|
1 | 16 | NA | M129 | U00089.2 | 99.7–99.9 | 99.5–99.9 | E179K (7), D559N (1), Q1232E (4) | 7–11 | 3 |
2 | 8 | NA | Mp1842 | AF290002.1 | 99.6–99.9 | 99.5–99.8 | S841L, E962D, I1302V | 7–11 | 1 |
3 | 2a | Mpn309 | AP012303.1 | 99.8–99.9 | 99.5–99.6 | Y210N (1), T837N (3) | 6 | 0 | |
8 | 2b | T-103 | AB691539.1 | 99.5–99.9 | 99.5–99.9 | S1516P: 6 isolates had a deletion at 1244-QTNS-1247 | 7–9 | 1 | |
7 | 2c | P033 | JN048891.1 | 99.8–100 | 99.7–100 | V1411E | 7–9 | 0 |
*VTR, variable tandem repeat. NA, not applicable (strains M129 and Mp1842 are considered prototypes representative for types 1 and 2).
†The sequences of the P1 gene generated in this study have been deposited in GenBank (accession nos. KF154740–KF154759).
Page created: August 20, 2013
Page updated: August 20, 2013
Page reviewed: August 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.